Hua Luo
Psychiatry · Anderson, INNPI 1659439149
Payments from drug & device makers
Across 138 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$385
- Teva Pharmaceuticals USA, Inc.$353
- Otsuka America Pharmaceutical, Inc.$352
- AbbVie$309
- E.r. Squibb & Sons, L.L.C.$298
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$291
- plus $645 from 9 others
What the payments were for
- Food & beverage$2,52296%
- Education$1114%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 21 | $385 |
| Teva Pharmaceuticals USA, Inc. | 14 | $353 |
| Otsuka America Pharmaceutical, Inc. | 18 | $352 |
| AbbVie | 20 | $309 |
| E.r. Squibb & Sons, L.L.C. | 18 | $298 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $291 |
| Alkermes, Inc. | 14 | $288 |
| Indivior Inc. | 4 | $113 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Gilead | 2 | $43 |
| Lilly USA, LLC | 2 | $40 |
| Luye Pharma (USA) Ltd. | 2 | $36 |
| Lundbeck LLC | 2 | $32 |
| Exact Sciences | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
How this compares
$2,634 in reported general payments places this provider in the 75th percentile of 514 psychiatry providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 202 | $584,963 |
| IngrezzaValbenazine Tosylate | 16 | $116,406 |
| Abilify MaintenaAripiprazole | 43 | $116,017 |
| Invega TrinzaPaliperidone Palmitate | 11 | $98,949 |
| RexultiBrexpiprazole | 29 | $48,168 |
| PerserisRisperidone | 11 | $34,630 |
| Clozapine | 313 | $22,920 |
| VraylarCariprazine Hcl | 13 | $19,648 |
| Risperidone ErRisperidone Microspheres | 16 | $17,922 |
| Lurasidone Hcl | 30 | $13,268 |
| Aripiprazole | 115 | $12,589 |
| TrintellixVortioxetine Hydrobromide | 22 | $12,110 |
| Paliperidone ErPaliperidone | 33 | $11,699 |
| Olanzapine | 157 | $7,287 |
| Clozapine OdtClozapine | 14 | $6,802 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $352 | $164,18472 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $385 | $116,40616 claims |
| Indivior Inc.Perseris | $113 | $34,63011 claims |
| AbbVieVraylar | $309 | $19,64813 claims |
| Lilly USA, LLCOlanzapine | $40 | $7,287157 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 514 psychiatry providers in Indiana.
Other psychiatry in Anderson
- Muhammad MunirAnderson$92K
- Andrew SkinnerAnderson$17K
- Steven PaulCarmel$2.9M
- Jay FawverAngola$1.4M
- Suhayl NasrMichigan City$788K
- Christopher BojrabCarmel$714K
- Joseph FanelliMunster$443K
- Anantha ShekharIndianapolis$433K
- Eric JaggersJeffersonville$260K
- Larry LambertsonFort Wayne$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.